The Long Run with Luke Timmerman
Timmerman Report
"The Long Run"
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Episodes
Mentioned books
Oct 13, 2020 • 1h 6min
Ep78: Pearl Huang on Exoneural Cancer Biology
Pearl Huang, CEO of Cygnal Therapeutics, on Exoneural Cancer Biology
Sep 29, 2020 • 1h 21min
Ep77: Jennifer Petter on Drugging RNA Targets
Jennifer Petter, CSO of Arrakis Therapeutics, on small molecule drugs for RNA targets
Sep 8, 2020 • 1h 9min
Ep76: Otello Stampacchia on Becoming a Biotech VC
Otello Stampacchia on becoming a biotech venture capitalist.
Aug 10, 2020 • 1h 4min
Ep75: Rosana Kapeller on Drugging the Repeatome
Rosana Kapeller, CEO of ROME Therapeutics
Jul 21, 2020 • 1h 16min
Ep74: Abe Ceesay's Path to Leadership
Abe Ceesay, CEO of Tiburio Therapeutics
Jul 7, 2020 • 1h 5min
Ep73: Kevin Ness on Digital Genome Engineering
Ep73: Kevin Ness on Digital Genome Engineering by Timmerman Report
Jun 13, 2020 • 35min
Conversation on Race with Ted Love
Ted Love, CEO of Global Blood Therapeutics, on Racial Inequity
Jun 10, 2020 • 42min
Ep71: Andy Plump
Takeda R&D president Andy Plump on fighting COVID19 and racism.
May 26, 2020 • 1h 5min
Ep70: Nina Kjellson
Nina Kjellson forging a path in biotech venture capital.
May 14, 2020 • 35min
Vaccine Strategy with Larry Corey
Ep69 of The Long Run with virologist Larry Corey


